Barclays Upgrades Arcturus Therapeutics (ARCT) to Equalweight

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/15/2026

1. AMAT
2. SPY
3. GLOB
4. RDDT
5. HTFL
6. SNDK
7. WDAY
8. ADYEN:NA
9. DVLT
10. ADYYF

November 2, 2022 7:17 AM EDT
Get Alerts ARCT Hot Sheet
Price: $8.23 +4.71%

Rating Summary:
    13 Buy, 5 Hold, 3 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE

Barclays analyst Gena Wang upgraded Arcturus Therapeutics (NASDAQ: ARCT) from Underweight to Equalweight with a price target of $25.00 (from $16.00).


For an analyst ratings summary and ratings history on Arcturus Therapeutics click here. For more ratings news on Arcturus Therapeutics click here.


Shares of Arcturus Therapeutics closed at $18.28 yesterday.


You May Also Be Interested In





Related Categories

Analyst PT Change, Upgrades